Search Results

Oseltamivir phosphate interaction with model membranes.

• Authors : Čelková A; Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov10, 832 32 Bratislava, Slovakia.; Búcsi A

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/chemistry ; Oseltamivir*/Oseltamivir*/Oseltamivir*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology

• Source: Biochimica et biophysica acta. Biomembranes [Biochim Biophys Acta Biomembr] 2024 Mar; Vol. 1866 (3), pp. 184273. Date of Electronic Publication: 2024 Jan 09.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731713 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.

• Authors : Cheemarla NR; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/pharmacology ; Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

• Source: The Journal of infectious diseases [J Infect Dis] 2024 May 15; Vol. 229 (5), pp. 1430-1434.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

• Authors : Li Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.; Wang X

Subjects: Dibenzothiepins*/Dibenzothiepins*/Dibenzothiepins*/adverse effects ; Triazines*/Triazines*/Triazines*/adverse effects ; Oseltamivir*/Oseltamivir*/Oseltamivir*/adverse effects

• Source: BMC infectious diseases [BMC Infect Dis] 2024 May 09; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 May 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

A case of amenorrhea: Caused by Oseltamivir or Influenza a virus?

• Authors : Zhou P; Department of Pharmacy, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China.; Li S

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/adverse effects ; Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; Amenorrhea*/Amenorrhea*/Amenorrhea*/chemically induced

• Source: American journal of reproductive immunology (New York, N.Y. : 1989) [Am J Reprod Immunol] 2024 May; Vol. 91 (5), pp. e13867.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 8912860 Publication Model: Print Cited Medium: Internet ISSN: 1600-0897

Record details

Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.

• Authors : Ikematsu H; Ricerca Clinica, Fukuoka, Japan.; Baba T

Subjects: Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control ; Influenza, Human*/Influenza, Human*/Influenza, Human*/transmission

• Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13302.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

Effectiveness of oseltamivir in reducing COVID-19-related in-hospital deaths: A pharmacoepidemiological study.

• Authors : Leung C; Department of Population Health Sciences, University of Leicester, Leicester, UK. Electronic address: .; Su L

Subjects: COVID-19* ; Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use; Humans

• Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Apr; Vol. 63 (4), pp. 107111. Date of Electronic Publication: 2024 Feb 12.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Does oseltamivir prevent hospitalisation in people with influenza?

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control

• Source: Drug and therapeutics bulletin [Drug Ther Bull] 2024 Mar 25; Vol. 62 (4), pp. 52. Date of Electronic Publication: 2024 Mar 25.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0112037 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-5248

Record details

Misclassification of Both Influenza Infection and Oseltamivir Exposure Status in Administrative Data.

• Authors : Bassett HK; Division of Hospital Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.; Coon ER

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; Influenza, Human*/Influenza, Human*/Influenza, Human*/epidemiology

• Source: JAMA pediatrics [JAMA Pediatr] 2024 Feb 01; Vol. 178 (2), pp. 201-203.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Oseltamivir May or May Not Reduce Hospitalizations.

• Authors : Uyeki TM; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia.; Hui DSC

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control

• Source: JAMA internal medicine [JAMA Intern Med] 2024 Jan 01; Vol. 184 (1), pp. 116.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Corrections to a Meta-Analysis of Oseltamivir Use in Preventing Hospitalization for Influenza.

• Authors : Lee TC; Centre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Experimental Medicine and Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control

• Source: JAMA internal medicine [JAMA Intern Med] 2024 Jan 01; Vol. 184 (1), pp. 115-116.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN:

Record details